Washington Patent of the Month – October 2023
Hepatitis C virus (HCV) is an infection of the liver which affects millions of people worldwide. Cocrystal Pharma, Inc., a clinical-stage biotechnology company, is working to leverage their core competencies to develop treatments for viral infections. One treatment in their pipeline is focused on tackling HCV, utilizing direct acting antiviral drugs (DAAs) to target all HCV genotypes.
HCV is a complex and rapidly mutating virus, making it difficult to develop effective treatments. The currently approved therapies, which include interferon-based regimens, often come with unpleasant side effects and varying success rates, especially depending on the HCV genotype.
Cocrystal Pharma’s approach for treating HCV addresses the need for more efficient and tolerable treatment options. This method involves a combination therapy that includes “Compound A” – one of Cocrystal Pharma’s proprietary pharmaceuticals – and a second HCV inhibitor, such as NS5B, NS5A, or protease inhibitors. The key to this innovative approach lies in the synergistic effect of combining different classes of inhibitors, which can enhance treatment efficacy.
This method isn’t limited to the treatment of HCV genotypes alone; it offers hope for those who are co-infected with HIV or HBV, broadening the spectrum of treatment possibilities. Moreover, the treatment duration is shorter than traditional therapies, lasting just four to eight weeks in some cases.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
